GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 776 - 800 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▼ Arbitrary Fluorescence Units (AFU)
IgM Patient 3 11 mild
G81315DD
715
IgM Patient 3 4 mild
G81315DD
468
IgA Patient 4 12 mild
G81315DD
5922
IgG Patient 4 12 mild
G81315DD
4208
IgM Patient 4 12 mild
G81315DD
11721
IgA Patient 1 10 moderate
G80587NA
424
IgA Patient 1 22 moderate
G80587NA
486
IgA Patient 1 6 moderate
G80587NA
520
IgG Patient 1 10 moderate
G80587NA
59
IgG Patient 1 22 moderate
G80587NA
68
IgM Patient 1 10 moderate
G80587NA
437
IgM Patient 1 22 moderate
G80587NA
570
IgA Patient 2 15 mild
G80587NA
807
IgA Patient 2 24 mild
G80587NA
925
IgG Patient 2 15 mild
G80587NA
794
IgG Patient 2 24 mild
G80587NA
975
IgM Patient 2 15 mild
G80587NA
1497
IgM Patient 2 24 mild
G80587NA
1761
IgG Patient 1 6 moderate
G80587NA
87
IgM Patient 1 6 moderate
G80587NA
705
IgA Patient 2 3 mild
G80587NA
923
IgG Patient 2 3 mild
G80587NA
895
IgM Patient 2 3 mild
G80587NA
1793
IgA Patient 3 -180 mild
G80587NA
889
IgA Patient 3 11 mild
G80587NA
1164

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024